Sirona Biochem Corp.
SRBCF
Rank in Stocks
#32638
Sirona Biochem Corp. operates as a biotechnology company dedicated to... Sirona Biochem Corp. operates as a biotechnology company dedicated to uncovering and commercializing active ingredients for both cosmetic and pharmaceutical uses, with a commercial presence in Canada and France. Key initiatives include the development of a cosmetic skin brightener and a pharmaceutical solution for diabetes. Beyond these, the company is engaged in several other projects, such as building a library of anti-aging and cell-protective compounds, creating a novel anti-wrinkle agent, and pursuing an antiviral research program. A notable collaboration exists with the International Centre for Genetic Engineering and Biotechnology (ICGEB) for the joint development of an antiviral compound library. Established in 2006, the business, originally named High Rider Capital Inc., rebranded as Sirona Biochem Corp. in May 2009 and maintains its headquarters in Vancouver, Canada.
Share Price
$0.0051
Last synced: 2026-11-09
Market Cap
$1.32M
Change (1 day)
0.00%
Change (1 year)
5,000.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Sirona Biochem Corp. (SRBCF)
Category
Healthcare
Operating Margin for Sirona Biochem Corp. (SRBCF)
Operating Margin as of November 2026 TTM: -6,917.60%
According to Sirona Biochem Corp.'s latest financial reports, its current operating margin (TTM) is -6,917.60%. At the end of 2023 the company had an operating margin of -6,917.60%.
Operating Margin history for Sirona Biochem Corp. from 2006 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -6,917.60% | 0.00% |
| 2023 | -6,917.60% | 1,202.60% |
| 2022 | -531.06% | -39.36% |
| 2021 | -875.80% | -77.08% |
| 2020 | -3,821.29% | 16.73% |
| 2019 | -3,273.50% | 4,489.88% |
| 2018 | -71.32% | -99.84% |
| 2017 | -45,534.24% | 5,494.92% |
| 2016 | -813.85% | -98.14% |
| 2015 | -43,741.94% | 2,509.93% |
| 2014 | -1,675.98% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
| 2007 | 0.00% | 0.00% |
| 2006 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.01% |
US
|
|
| -149.01% | -99.98% |
US
|
|
| 25.57% | -100.00% |
AU
|
|
| 31.23% | -100.00% |
BE
|
|
| 29.35% | -100.00% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Sirona Biochem Corp.'s operating margin
What is Sirona Biochem Corp.'s operating margin?
Sirona Biochem Corp.'s operating margin is -6,917.60%, as of Nov 2026.
What was Sirona Biochem Corp.'s operating margin in 2023?
In 2023, Sirona Biochem Corp.'s operating margin was -6,917.60%, compared with -531.06% in 2022.
How has Sirona Biochem Corp.'s operating margin changed since 2018?
From 2018 to 2023, Sirona Biochem Corp.'s operating margin was highest in 2018 (-71.32%) and lowest in 2023 (-6,917.60%).
How does Sirona Biochem Corp.'s operating margin compare with similar companies?
Sirona Biochem Corp.'s operating margin (-6,917.60%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.